Report cover image

Europe Liver Fibrosis Treatment Market

Publisher Data Bridge Market Research
Published Apr 01, 2025
Length 350 Pages
SKU # DAABD20406800

Description

Europe liver fibrosis treatment market is expected to reach USD 11.04 billion by 2032 from USD 5.06 billion in 2024, growing at a substantial CAGR of 10.3% in the forecast period of 2025 to 2032.

Market Segmentation:
Europe Liver Fibrosis Treatment Market, By Treatment Type (Medication and Surgery/Therapy), Stages ( F2, F1, F3, and F4), Indication (Non-Alcoholic Steatohepatitis (NASH), Hepatitis B & C-Induced Fibrosis, Alcoholic Liver Disease (ALD), Autoimmune Liver Diseases, Genetic Disorders, and Others), Gender(Male and Female), End User (Hospitals, Specialty Clinics, Clinics, Ambulatory and Research Centers, and Others), Distribution Channel (Direct Tender and Retail Sales), Country (Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Belgium, Netherlands, Switzerland, Denmark, Sweden, Norway, Finland, and Rest of Europe) - Industry Trends & Forecast To 2032
Overview of Europe Liver Fibrosis Treatment Market Dynamics:

Driver

• Increasing Prevalence of Liver Diseases
Restraint

• Limited Awareness of Liver Diseases
Opportunity

• Progress in Pipeline Products for Liver Fibrosis Treatment
Market Players:

The key market players operating in the Europe liver fibrosis treatment market are listed below:

• Gilead Sciences, Inc.
• AbbVie Inc.
• Merck & Co., Inc.
• Novartis AG
• Intercept Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd
• Abbott
• La Renon Healthcare Pvt. Ltd.
• GENFIT SA
• Madrigal Pharmaceuticals
• Aligos Therapeutics
• Pfizer Inc.
• Enanta Pharmaceuticals, Inc.
• Bristol-Myers Squibb Company
• Vertex Pharmaceuticals Incorporated
• Takeda Pharmaceutical Company Limited
• Hepion Pharmaceuticals
• Echosens
• Galectin Therapeutics, Inc.
• Conatus Pharmaceuticals
• Tvardi Therapeutics
• Viking Therapeutics
• Calliditas Therapeutics AB
• Novomedix
• Galecto Biotech
• Pilant Therapeutics, Inc.
• Sagimet Biosciences
• Gyre Therapeutics, Inc.
• Akero Therapeutics, Inc.
• CureVac SE
• Novo Nordisk A/S
• Ipsen Pharma
• AdAlta Limited
• Alentis Therapeutics AG


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Liver Fibrosis Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Multivariate Modelling
2.6 Treatment Type Lifeline Curve
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market End User Coverage Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestal Analysis
4.2 Porters Five Forces Analysis
4.2.1 Liver Transplantation Volume And Their Cost For Liver Fibrosis By Country
4.2.2 Endoscopic & Minimally Invasive Procedures For Liver Fibrosis: Volume And Cost By Country
4.2.3 Partial Hepatectomy (Liver Resection) Cost By Country
4.2.4 Cell-based Therapy Cost For Liver Fibrosis Treatment By Country
4.3 Epidemiology
4.3.1 Incidence Of All By Gender
4.3.2 Treatment Rate
4.3.3 Treatment Rate
4.3.4 Drug Adherence And Therapy Switch Model
4.3.5 Patient Treatment Success Rates
4.4 Marketed Drug Analysis
4.5 Demographic Trends: Impacts On All Incidence Rates
4.5.1 Patient Flow Diagram
4.5.2 Key Pricing Strategies
4.5.3 Key Patient Enrollment Strategies
5 Europe Liver Fibrosis Treatment Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Increasing Prevalence Of Liver Diseases
6.1.2 Rising Consumption Of Alcohol
6.1.3 Rising Liver Transplantation Rates
6.1.4 Growing Incidence Of Non-alcoholic Fatty Liver Disease (Nafld) & Nash
6.2 Restraints
6.2.1 Limited Awareness Of Liver Diseases
6.2.2 Regulatory Challenges
6.3 Opportunities
6.3.1 Emerging Technologies And Advanced Treatments In Liver Fibrosis Management
6.3.2 Progress In Pipeline Products For Liver Fibrosis Treatment
6.3.3 Strategic Mergers And Acquisitions Among The Key Players
6.4 Challenges
6.4.1 Lack Of Effective And Approved Anti-fibrotic Drugs
6.4.2 High Cost Of Treatments In Liver Fibrosis Care
7 Europe Liver Fibrosis Treatment Market, By Treatment Type
7.1 Overview
7.2 Medication
7.2.1 Antiviral Agents
7.2.1.1 Velpatasvir/Sofosbuvir
7.2.1.2 Tenofovir
7.2.1.3 Ledipasvir/Sofosbuvir
7.2.1.4 Sofosbuvir
7.2.1.5 Entecavir
7.2.2 Antifibrotic Agents
7.2.2.1 Obeticholic Acid
7.2.2.2 Tgf-β Inhibitors
7.2.2.3 Connective Tissue Growth Factor (Ctgf) Inhibitors
7.2.2.4 Lysyl Oxidase-like 2 (Loxl2) Inhibitors
7.2.2.5 Others
7.2.3 Anti-inflammatory Drugs
7.2.3.1 Corticosteroids
7.2.3.1.1 Prednisone
7.2.3.1.2 Dexamethasone
7.2.3.2 Tumor Necrosis Factor (Tnf) Inhibitors
7.2.3.2.1 Infliximab
7.2.3.2.2 Etanercept
7.2.3.3 Interleukin (Il) Inhibitors
7.2.3.3.1 Il-6 Inhibitors (Tocilizumab)
7.2.3.3.2 Il-1 Inhibitors (Anakinra)
7.2.4 Immunosuppressants
7.2.4.1 Mycophenolate Mofetil
7.2.4.2 Tacrolimus
7.2.4.3 Cyclosporine
7.2.5 Marketed Drugs
7.2.5.1 Velpatasvir/Sofosbuvir
7.2.5.2 Tenofovir
7.2.5.3 Ledipasvir/Sofosbuvir
7.2.5.4 Obeticholic Acid (Oca)
7.2.5.5 Sofosbuvir
7.2.5.6 Pirfenidone
7.2.5.7 Others
7.2.6 Pipeline Drugs
7.2.7 Branded Drugs
7.2.7.1 Epclusa
7.2.7.2 Viread And Vemlidy
7.2.7.3 Ocaliva
7.2.7.4 Harvoni
7.2.7.5 Sovaldi
7.2.7.6 Baraclude
7.2.7.7 Actos
7.2.7.8 Others
7.2.8 Generic Drugs
7.2.9 Oral
7.2.10 Parenteral
7.2.11 Others
7.3 Surgery/Therapy
7.3.1 Liver Transplantation
7.3.2 Orthotopic Liver Transplant (Olt)
7.3.3 Living Donor Liver Transplant (Ldlt)
7.3.4 Split Liver Transplantation
7.3.5 Domino Liver Transplant
7.3.6 Endoscopic & Minimally Invasive Procedures
7.3.6.1 Endoscopic Variceal Ligation (Evl)
7.3.6.2 Transjugular Intrahepatic Portosystemic Shunt (Tips)
7.3.6.3 Liver Ablation Procedures
7.3.6.3.1 Radiofrequency Ablation (Rfa)
7.3.6.3.2 Microwave Ablation (Mwa)
7.3.7 Partial Hepatectomy (Liver Resection)
7.3.7.1 Segmental Resection
7.3.7.2 Lobectomy
7.3.7.3 Wedge Resection
7.3.8 Cell-based Therapy
7.3.8.1 Stem Cell Therapy
7.3.8.1.1 Mesenchymal Stem Cells (Mscs)
7.3.8.1.2 Hematopoietic Stem Cells (Hscs)
7.3.8.2 Gene Therapy
7.3.8.2.1 Crispr-based Liver Regeneration
7.3.8.2.2 Hepatic Stellate Cell (Hsc) Inhibitors
7.3.8.2.3 Sirna-based Therapies
7.3.8.2.4 Hepatocyte Apoptosis Inhibitors
7.3.8.2.4.1 Oxidative Stress Inhibitors
7.3.8.2.4.2 Emricasan
7.3.8.2.4.3 Pentoxifylline
7.3.8.2.4.4 Losartan
7.3.8.2.4.5 Methyl Ferulic Acid
7.3.8.2.4.6 Others
7.4 Others
8 Europe Liver Fibrosis Treatment Market, By Stages
8.1 Overview
8.2 F2
8.3 F1
8.4 F3
8.5 F4
9 Europe Liver Fibrosis Treatment Market, By Indication
9.1 Overview
9.2 Non-alcoholic Steatohepatitis (Nash)
9.3 Hepatitis B & C-induced Fibrosis
9.3.1 Chronic Hepatitis B Virus (Hbv) Fibrosis
9.3.2 Chronic Hepatitis C Virus (Hcv) Fibrosis
9.4 Alcoholic Liver Disease (Ald)
9.5 Autoimmune Liver Diseases
9.5.1 Autoimmune Hepatitis (Aih)
9.5.2 Primary Biliary Cholangitis (Pbc)
9.5.3 Primary Sclerosing Cholangitis (Psc)
9.6 Genetic Disorders
9.6.1 Hemochromatosis
9.6.2 Wilson’s Disease
9.6.3 Alpha-1 Antitrypsin Deficiency
9.7 Others
10 Europe Liver Fibrosis Treatment Market, By Gender
10.1 Overview
10.2 Male
10.2.1 40-55 Years
10.2.2 Above 55 Years
10.2.3 Below 40 Years
10.3 Female
10.3.1 Above 55 Years
10.3.2 40-55 Years
10.3.3 Below 40 Years
11 Europe Liver Fibrosis Treatment Market, By End User
11.1 Overview
11.2 Hospitals
11.2.1 Public Hospitals
11.2.2 Private Hospitals
11.3 Specialty Clinics
11.3.1 Hepatology Clinics
11.3.2 Gastroenterology Clinics
11.4 Clinics
11.5 Ambulatory And Research Centers
11.6 Others
12 Europe Liver Fibrosis Treatment Market, By Distribution Channel
12.1 Overview
12.2 Direct Tender
12.2.1 Retail Sales
12.2.1.1 Hospital Pharmacy
12.2.1.2 Retail Pharmacy
12.2.1.3 Online Pharmacy
13 Europe Liver Fibrosis Treatment Market, By Region
13.1 Europe
13.1.1 Germany
13.1.2 France
13.1.3 U.K.
13.1.4 Italy
13.1.5 Spain
13.1.6 Switzerland
13.1.7 Russia
13.1.8 Belgium
13.1.9 Netherlands
13.1.10 Turkey
13.1.11 Poland
13.1.12 Sweden
13.1.13 Norway
13.1.14 Denmark
13.1.15 Finland
13.1.16 Rest Of Europe
14 Europe Liver Fibrosis Treatment Market: Company Landscape
14.1 Company Share Analysis: Global
15 Swot Analysis
16 Company Profiles
16.1 Gilead Sciences, Inc.
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Development/News
16.2 Abbvie, Inc.
16.2.1 Company Snapshot
16.2.2 Revenue Analysis
16.2.3 Company Share Analysis
16.2.4 Product Portfolio
16.2.5 Recent Development
16.3 Merck & Co, Inc.
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Development
16.4 Novartis Ag
16.4.1 Company Snapshots
16.4.2 Revenue Analysis And Segmented Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Pipeline Product Portfolio
16.4.6 Recent Development
16.5 Intercept Pharmaceuticals, Inc.
16.5.1 Company Snapshots
16.5.2 Company Share Analysis
16.5.3 Revenue Analysis And Segmented Analysis
16.5.4 Product Portfolio
16.5.5 Pipeline Product Portfolio
16.5.6 Recent News
16.6 Abbott
16.6.1 Company Snapshot
16.6.2 Revenue Analysis
16.6.3 Product Portfolio
16.6.4 1.1.5 Recent Development
16.7 Aligos Therapeutics
16.7.1 Company Snapshot
16.7.2 Revenue Analysis
16.7.3 Product Portfolio
16.7.4 Recent Development
16.8 Alniche Life Sciences Pvt. Ltd.
16.8.1 Company Snapshot
16.8.2 Product Portfolio
16.8.3 Recent Development
16.9 Alentis Therapeutics Ag
16.9.1 Company Snapshot
16.9.2 Pipeline Product Portfolio
16.9.3 Recent Development
16.10 Adalta Limited
16.10.1 Company Snapshot
16.10.2 Revenue Analysis
16.10.3 Pipeline Product Portfolio
16.10.4 Recent News
16.11 Akero Therapeutics, Inc.
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Pipeline Product Portfolio
16.11.4 Recent Development
16.12 Bristol-myers Squibb
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Development
16.13 Calliditas Therapeutics Ab
16.13.1 Company Snapshot
16.13.2 Pipeline Product Portfolio
16.13.3 Recent Development
16.14 Curevac Se
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Conatuspharma
16.15.1 Company Snapshot
16.15.2 Product Portfolio
16.15.3 Recent Development/News
16.16 Enanta Pharmaceuticals, Inc.
16.16.1 Company Snapshot
16.16.2 Revenue Analysis
16.16.3 Product Portfolio
16.16.4 Recent Development
16.17 Echosens
16.17.1 Company Snapshot
16.17.2 Product Portfolio
16.17.3 Recent Development/News
16.18 F. Hoffmann-la Roche Ltd
16.18.1 Company Snapshot
16.18.2 Revenue Analysis
16.18.3 Company Share Analysis
16.18.4 Product Portfolio
16.18.5 Recent Development
16.19 Galecto Biotech
16.19.1 Company Snapshot
16.19.2 Revenue Analysis
16.19.3 Pipeline Product Portfolio
16.19.4 Recent Development/News
16.20 Galectin Therapeutics, Inc.
16.20.1 Company Snapshots
16.20.2 Revenue Analysis And Segmental Analysis
16.20.3 Pipeline Product Portfolio
16.20.4 Recent Development
16.21 Gyre Therapeutics, Inc.
16.21.1 Company Snapshot
16.21.2 Revenue Analysis And Segmented Analysis
16.21.3 Product Portfolio
16.21.4 Recent Development/News
16.22 Genfit Sa
16.22.1 Company Snapshots
16.22.2 Revenue Analysis And Segmented Analysis
16.22.3 Pipeline Product Portfolio
16.22.4 Recent Development
16.23 Hepion Pharmaceuticals
16.23.1 Company Snapshot
16.23.2 Revenue Analysis
16.23.3 Pipeline Portfolio
16.23.4 Recent Development
16.24 Ipsen Pharma
16.24.1 Company Snapshot
16.24.2 Revenue Analysis
16.24.3 Pipeline Product Portfolio
16.24.4 Recent News/Developments
16.25 La Renon Healthcare Pvt. Ltd.
16.25.1 Company Snapshot
16.25.2 Product Portfolio
16.25.3 Recent Development
16.26 Madrigal Pharmaceuticals
16.26.1 Company Snapshots
16.26.2 Revenue Analysis And Segmented Analysis
16.26.3 Product Portfolio
16.26.4 Recent Development
16.27 Novo Nordisk A/S
16.27.1 Company Snapshot
16.27.2 Revenue Analysis
16.27.3 Pipeline Product Portfolio
16.27.4 Recent Development
16.28 Novomedix
16.28.1 Company Snapshot
16.28.2 Pipeline Product Portfolio
16.28.3 Recent Development
16.29 Pilant Therapeutics, Inc.
16.29.1 Company Snapshot
16.29.2 Revenue Analysis
16.29.3 Pipeline Product Portfolio
16.29.4 Recent News
16.30 Pfizer Inc.
16.30.1 Company Snapshot
16.30.2 Revenue Analysis
16.30.3 Pipeline Product Portfolio
16.30.4 Recent Development/News
16.31 Sagimet Biosciences
16.31.1 Company Snapshots
16.31.2 Revenue Analysis
16.31.3 1.1.4 Product Portfolio
16.31.4 Recent Development/News
16.32 Takeda Pharmaceutical Company Limited
16.32.1 Company Snapshot
16.32.2 Revenue Analysis
16.32.3 Pipeline Product Portfolio
16.32.4 Product Portfolio
16.32.5 Recent Development
16.33 Tvardi Therapeutics
16.33.1 Company Snapshot
16.33.2 Pipeline Product Portfolio
16.33.3 Recent Development/News
16.34 Vertex Pharmaceuticals Incorporated
16.34.1 Company Snapshot
16.34.2 Revenue Analysis
16.34.3 Product Portfolio
16.34.4 Recent Development
16.35 Viking Therapeutics
16.35.1 Company Snapshot
16.35.2 Revenue Analysis
16.35.3 Pipeline Product Portfolio
16.35.4 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables
Table 1 Asia-pacific Incidence Of Cirrhosis By Gender (2019)
Table 2 Treatment Adherence Levels In Liver Disease Patients
Table 3 Asia-pacific Liver Fibrosis Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand)
Table 4 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 5 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 6 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 7 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 8 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 9 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 10 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 11 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 12 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 13 Asia-pacific Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 14 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 15 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 16 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 17 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 18 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 19 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 20 Asia-pacific Interleukin (Il) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 21 Asia-pacific Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 22 Asia-pacific Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 23 Asia-pacific Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 24 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 25 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 26 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 27 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Drug Status, 2018-2032 (Usd Thousand)
Table 28 Asia-pacific Marketed Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 29 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 30 Asia-pacific Branded Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 31 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Route Of Administration, 2018-2032 (Usd Thousand)
Table 32 Asia-pacific Surgery/Therapy In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 33 Asia-pacific Surgery/Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 34 Asia-pacific Liver Transplantation In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 35 Asia-pacific Endoscopic & Minimally Invasive Procedures In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 36 Asia-pacific Liver Ablation Procedures In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 37 Asia-pacific Partial Hepatectomy (Liver Resection) In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 38 Asia-pacific Cell-based Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 39 Asia-pacific Stem Cell Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 40 Asia-pacific Gene Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 41 Asia-pacific Hepatocyte Apoptosis Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 42 Asia-pacific Liver Fibrosis Treatment Market, By Stages, 2018-2032 (Usd Thousand)
Table 43 Asia-pacific F2 In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 44 Asia-pacific F1 In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 45 Asia-pacific F3 In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 46 Asia-pacific F4 In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 47 Asia-pacific Liver Fibrosis Treatment Market, By Indication, 2018-2032 (Usd Thousand)
Table 48 Asia-pacific Non-alcoholic Steatohepatitis (Nash) In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 49 Asia-pacific Hepatitis B & C-induced Fibrosis In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 50 Asia-pacific Hepatitis B & C-induced Fibrosis In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 51 Asia-pacific Alcoholic Liver Disease (Ald) In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 52 Asia-pacific Autoimmune Liver Diseases In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 53 Asia-pacific Autoimmune Liver Diseases In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 54 Asia-pacific Genetic Disorders In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 55 Asia-pacific Genetic Disorders In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 56 Asia-pacific Others In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 57 Asia-pacific Liver Fibrosis Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 58 Asia-pacific Male In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 59 Asia-pacific Male In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 60 Asia-pacific Female In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 61 Asia-pacific Female In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 62 Asia-pacific Liver Fibrosis Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 63 Asia-pacific Hospitals In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 64 Asia-pacific Hospitals In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 65 Asia-pacific Specialty Clinics In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 66 Asia-pacific Specialty Clinics In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 67 Asia-pacific Clinics In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 68 Asia-pacific Ambulatory And Research Centers In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 69 Asia-pacific Others In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 70 Asia-pacific Liver Fibrosis Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 71 Asia-pacific Direct Tender In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 72 Asia-pacific Retail Sales In Liver Fibrosis Treatment Market, By Region, 2018-2032 (Usd Thousand)
Table 73 Asia-pacific Retail Sales In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 74 Asia-pacific Liver Fibrosis Treatment Market, By Country, 2018-2032 (Usd Thousand)
Table 75 Asia-pacific Liver Fibrosis Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand)
Table 76 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 77 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 78 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 79 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 80 Asia-pacific Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 81 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 82 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 83 Asia-pacific Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 84 Asia-pacific Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 85 Asia-pacific Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 86 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 87 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 88 Asia-pacific Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 89 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 90 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 91 Asia-pacific Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 92 Asia-pacific Interleukin (Il) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 93 Asia-pacific Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 94 Asia-pacific Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 95 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 96 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 97 Asia-pacific Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 98 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Drug Status, 2018-2032 (Usd Thousand)
Table 99 Asia-pacific Marketed Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 100 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Drug Type, 2018-2032 (Usd Thousand)
Table 101 Asia-pacific Branded Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 102 Asia-pacific Medication In Liver Fibrosis Treatment Market, By Route Of Administration, 2018-2032 (Usd Thousand)
Table 103 Asia-pacific Surgery/Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 104 Asia-pacific Liver Transplantation In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 105 Asia-pacific Endoscopic & Minimally Invasive Procedures In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 106 Asia-pacific Liver Ablation Procedures In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 107 Asia-pacific Partial Hepatectomy (Liver Resection) In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 108 Asia-pacific Cell-based Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 109 Asia-pacific Stem Cell Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 110 Asia-pacific Gene Therapy In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 111 Asia-pacific Hepatocyte Apoptosis Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 112 Asia-pacific Liver Fibrosis Treatment Market, By Stages, 2018-2032 (Usd Thousand)
Table 113 Asia-pacific Liver Fibrosis Treatment Market, By Indication, 2018-2032 (Usd Thousand)
Table 114 Asia-pacific Hepatitis B & C-induced Fibrosis In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 115 Asia-pacific Autoimmune Liver Diseases In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 116 Asia-pacific Genetic Disorders In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 117 Asia-pacific Liver Fibrosis Treatment Market, By Gender, 2018-2032 (Usd Thousand)
Table 118 Asia-pacific Male In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 119 Asia-pacific Female In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 120 Asia-pacific Liver Fibrosis Treatment Market, By End User, 2018-2032 (Usd Thousand)
Table 121 Asia-pacific Hospitals In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 122 Asia-pacific Specialty Clinics In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 123 Asia-pacific Liver Fibrosis Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
Table 124 Asia-pacific Retail Sales In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 125 China Liver Fibrosis Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand)
Table 126 China Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 127 China Medication In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 128 China Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 129 China Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 130 China Antiviral Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 131 China Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 132 China Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 133 China Antifibrotic Agents In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 134 China Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 135 China Anti-inflammatory Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 136 China Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 137 China Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 138 China Corticosteroids In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 139 China Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 140 China Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 141 China Tumor Necrosis Factor (Tnf) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 142 China Interleukin (Il) Inhibitors In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 143 China Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 144 China Interleukin (Il) Inhibitor In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 145 China Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
Table 146 China Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Volume In Thousand Units)
Table 147 China Immunosuppressants In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Asp In Usd/Units)
Table 148 China Medication In Liver Fibrosis Treatment Market, By Drug Status, 2018-2032 (Usd Thousand)
Table 149 China Marketed Drugs In Liver Fibrosis Treatment Market, By Type, 2018-2032 (Usd Thousand)
List Of Figures
Figure 1 Europe Liver Fibrosis Treatment Market: Segmentation
Figure 2 Europe Liver Fibrosis Treatment Market: Data Triangulation
Figure 3 Europe Liver Fibrosis Treatment Market: Droc Analysis
Figure 4 Europe Liver Fibrosis Treatment Market: Regional Market Analysis
Figure 5 Europe Liver Fibrosis Treatment Market: Company Research Analysis
Figure 6 Europe Liver Fibrosis Treatment Market: Interview Demographics
Figure 7 Europe Liver Fibrosis Treatment Market: Dbmr Market Position Grid
Figure 8 Europe Liver Fibrosis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us